Arax Advisory Partners’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113K Buy
2,531
+2,404
+1,893% +$86.6K ﹤0.01% 2640
2026
Q1
$4.09K Sell
127
-46
-27% -$1.63K ﹤0.01% 2881
2025
Q4
$6.23K Buy
173
+165
+2,063% +$6.06K ﹤0.01% 2731
2025
Q3
$251 Sell
8
-17
-68% -$610 ﹤0.01% 3431
2025
Q2
$1.06K Buy
+25
New +$1.04K ﹤0.01% 2755

Other funds holding VCEL

Arax Advisory Partners's VCEL Position: Q2 2026 in Review

Arax Advisory Partners increased its Vericel Corp (VCEL) stake by 1,893% in Q2 2026, buying an estimated $86.6K and bringing the position to 2,531 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #2640.

Arax Advisory Partners first reported a position in VCEL in Q2 2025 and has held it in 5 quarters since. 320 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Arax Advisory Partners held 2,531 shares of Vericel Corp worth $113K as of Q2 2026.
  • Arax Advisory Partners bought 2,404 Vericel Corp shares in Q2 2026, an estimated $86.6K.
  • Vericel Corp made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2640 holding.
  • Arax Advisory Partners first reported a position in Vericel Corp in Q2 2025 and has held it in 5 quarters since.
  • 320 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.